Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation

Clinical trial NCT01563458 · COMPLETED

Trial details

NCT number: NCT01563458
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acquired Bleeding Disorder Bleeding During/Following Surgery

Start date: 2001-08-01
Primary completion: 2003-08-01
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.